Search Within

Ouathek Ouerfelli

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (1)
Groups
  1. GSK Faculty (9)
  2. Human Oncology and Pathogenesis Program (9)
  3. Department of Medicine (7)
  4. Sloan Kettering Institute Postdocs (7)
  5. Tow Center for Developmental Oncology (TCDO) (7)
  6. Center for Hematologic Malignancies (6)

More Groups

People
  1. Elisa De Stanchina (6)
  2. Guangbin Yang (3)
  3. Inna Khodos (3)
  4. Omar Abdel-Wahab (3)
  5. Ross Levine (3)
  6. Alan Chramiec (2)

More People

Years
  1. 2021 (1)
  2. 2016 (2)
  3. 2015 (1)
  4. 2012 (2)
  5. 2010 (1)
  6. 2009 (1)

More Years

Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (2)
  3. Journal of Clinical Investigation (2)
  4. Nature Medicine (2)
Publishers
  1. American Association for Cancer Research (5)
  2. American Society for Clinical Investigation (2)
  3. Nature Publishing Group (2)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting germline- and tumor-associated nucleotide excision repair defects in cancer
    Journal Article

    Topka, S.; Steinsnyder, Z.; Ravichandran, V.; Tkachuk, K.; Kemel, Y.; Bandlamudi, C.; Madsen, M. W.; Furberg, H.; Ouerfelli, O.; Rudin, C. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Proteasome addiction defined in Ewing sarcoma is effectively targeted by a novel class of 19S proteasome inhibitors
    Journal Article

    Shukla, N.; Somwar, R.; Smith, R. S.; Ambati, S.; Munoz, S.; Merchant, M.; D'Arcy, P.; Wang, X.; Kobos, R.; Antczak, C.; more...
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Reply to "Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status"
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2016)

    Fulltext@MSK | Save
  • Loss of BAP1 function leads to EZH2-dependent transformation
    Journal Article

    LaFave, L. M.; Béguelin, W.; Koche, R.; Teater, M.; Spitzer, B.; Chramiec, A.; Papalexi, E.; Keller, M. D.; Hricik, T.; Konstantinoff, K.; more...
    Nature Medicine (2015)

    Fulltext@MSK | Save
  • Identification of the MUC16/CA125 interaction network: Results of a high-throughput yeast two-hybrid screening
    Meeting Abstract

    Polterauer, S.; Thapi, D.; Schultz, N.; Ouerfelli, O.; Chen, N.; Rosales, N.; Yan, X.; Spriggs, D. R.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • ARN-509: A novel antiandrogen for prostate cancer treatment
    Journal Article

    Clegg, N. J.; Wongvipat, J.; Joseph, J. D.; Tran, C.; Ouk, S.; Dilhas, A.; Chen, Y.; Grillot, K.; Bischoff, E. D.; Cai, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
    Journal Article

    Marubayashi, S.; Koppikar, P.; Taldone, T.; Abdel-Wahab, O.; West, N.; Bhagwat, N.; Caldas-Lopes, E.; Ross, K. N.; Gonen, M.; Gozman, A.; more...
    Journal of Clinical Investigation (2010)

    Fulltext@MSK | Save
  • Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer
    Journal Article

    Regales, L.; Gong, Y.; Shen, R.; de Stanchina, E.; Vivanco, I.; Goel, A.; Koutcher, J. A.; Spassova, M.; Ouerfelli, O.; Mellinghoff, I. K.; more...
    Journal of Clinical Investigation (2009)

    Fulltext@MSK | Save
  • Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors
    Journal Article

    Balak, M. N.; Gong, Y.; Riely, G. J.; Somwar, R.; Li, A. R.; Zakowski, M. F.; Chiang, A.; Yang, G.; Ouerfelli, O.; Kris, M. G.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save